Skip to main content
ASLMS 43rd Annual Conference (2024) Main banner
Back

    David M. Ozog, MD

    Chair Department of Dermatology Henry Ford Health, Professor in Medicine Michigan State University

    David M. Ozog, currently serves as Chair, Department of Dermatology and holds the C.S. Livingood Chair in Dermatology, at Henry Ford Hospital, Detroit, Michigan. He is also an active Mohs surgeon and Director of Cosmetic Dermatology. He received his undergraduate degree from the University of Michigan where he was a James B. Angell 4.0 GPA Scholar, completed post baccalaureate work at Bryn Mawr in Philadelphia and his medical degree from University of Rochester Medical School, Rochester, New York, where he was awarded AOA honors society. He completed his dermatology residency at Henry Ford Hospital, in Detroit, where he served as Chief Resident. His Mohs, Cosmetic and Procedural fellowship was with Dr. Ron Moy at UCLA Medical Center and Moy-Fincher Medical Group, in Beverly Hills, CA. He has published more than 90 articles and book chapters and has given hundreds of lectures nationally and internationally in various facets of procedural dermatology. His textbook, co-edited with Joel Cohen, Botulinum Toxins: Cosmetic and Clinical Applications, was published in 2017. Dr Ozog has directed sessions at the American Academy of Dermatology's annual meeting for several years. He was a member of the AAD coding committee, and he currently serves on the AAD Scientific Assembly Committee for a six-year term. He is scheduled to chair both Summer and Annual AAD meetings. He is also an editorial board member of JAMA Dermatology and an assistant editor of Dermatologic Surgery. His active research interests include cutaneous oncology, scarring prevention and treatment, botulinum toxins, as well as laser delivery for cosmetic and malignant conditions. He has trained more than 76 residents in dermatological surgery and was chosen by the residents as “Teacher of the Year.” Dr Ozog has taught hands on workshops nationally for the American Society for Dermatological Surgery, and he is co-director of the cadaver lab at Henry Ford. He enjoys biking and spending time with his wife Dawnmarie and their three children. Although his research group successfully pivoted to COVID work during the pandemic, he is thrilled to return to lasers and oncology, leaving spike proteins behind (hopefully forever).

    Presentation(s):